Making the case for med tech valuations

Deal Labs CEO Aaron Travis is bullish on investments in the medical device industry. "Medical devices may be a great place to look compared to pharmaceuticals. You're probably going to find favorable valuations versus other industries, like cloud computing, big data or social networking, where valuations are very robust," he said. He acknowledged that "it's been a rough kind of 10 years" because "the regulatory pathway has gotten more murky and access to funding has been difficult, especially due to all the changes in the way health care payers are organized in this insurance paradigm," but said that the sector now contains investment opportunities, and is one of his focus areas. In the past year, 17 medical device startups received $30 million from Deals Labs' funding strategy. More